Fusion Pharmaceuticals Inc. (FUSN) Social Stream



Fusion Pharmaceuticals Inc. (FUSN): $11.99

0.03 (+0.25%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

D

FUSION PHARMACEUTICALS INC (FUSN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering FUSN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 6 $24 $17 $20.2 $9.61 110.2%
2021-11-10 6 $20 $17 $19 $9.61 97.71%
2022-02-01 5 $20 $17 $19 $9.61 97.71%
2022-03-17 6 $20 $15 $18.2 $9.61 89.39%
2022-05-10 6 $21 $15 $18.4 $9.61 91.47%
2022-05-11 6 $21 $15 $18.2 $9.61 89.39%
2022-06-10 6 $19 $15 $17.8 $9.61 85.22%
2022-07-06 6 $19 $8.7 $16.14 $9.61 67.95%
2022-08-09 6 $19 $15 $18 $9.61 87.3%
2022-09-06 6 $19 $12 $16.25 $9.61 69.09%
2022-09-16 7 $19 $10 $15 $9.61 56.09%
2022-11-08 8 $19 $10 $15 $9.61 56.09%
2022-12-01 9 $19 $6 $13 $9.61 35.28%
2023-01-27 9 $19 $6 $11.714 $9.61 21.89%
2023-02-14 9 $19 $9 $12.428 $9.61 29.32%
2023-02-15 10 $20 $9 $13.625 $9.61 41.78%
2023-04-12 10 $20 $9 $13.875 $9.61 44.38%
2023-05-11 10 $20 $9 $14 $9.61 45.68%
2023-06-12 9 $20 $9 $14 $9.61 45.68%
2023-06-16 10 $20 $9 $14.375 $9.61 49.58%
2023-06-23 10 $20 $9 $13.25 $9.61 37.88%
2023-08-10 11 $20 $9 $13.222 $9.61 37.59%
2023-09-20 11 $20 $9 $13.111 $9.61 36.43%
2023-11-20 12 $20 $9 $13.1 $9.61 36.32%
2023-12-20 13 $20 $9 $13 $9.61 35.28%
2023-12-27 13 $20 $9 $13.272 $9.61 38.11%

The Trend in the Analyst Price Target


FUSN's average price target has moved down $9.23 over the prior 32 months.

Over the past 48 weeks, FUSN's average upside potential has been 238.59%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-17 10 20 9 13.875 4.15 234.34%
2023-03-30 10 20 9 13.875 3.86 259.46%
2023-05-11 9 20 9 14.000 4.52 209.73%
2023-06-16 9 20 9 14.375 4.45 223.03%
2023-06-23 11 20 9 13.222 4.49 194.48%

FUSN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.08 12 1 0 0 0 13

The Trend in the Broker Recommendations


Over the past 20 months, FUSN's average broker recommendation rating improved by 0.03.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for FUSN as an investment opportunity.

  • FUSN has a higher average analyst price target than 551.5% of all US stocks.
  • In the context of all US stocks, FUSION PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1790.96% of them.
  • In terms of how FUSION PHARMACEUTICALS INC fares relative to stocks in the small market cap category, note that its number of analysts covering the stock is greater than 2569.59% of that group.
  • In the context of Pharmaceutical Products stocks, FUSION PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 1040.72% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to FUSION PHARMACEUTICALS INC are FRLN, INBX, and HUMA.

Make investment decisions regarding FUSN using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!